APOE and glioblastoma: Researchers are exploring nanoparticle‐based systems to address these limitations and reduce systemic toxicities.[35, 36, 37] For example, Apolipoprotein E (ApoE) is being studied to enhance drug delivery to the brain.[36] ApoE interacts with BBB receptors, which are also present in glioblastoma cells.